Thoracic Cancer
68
18
22
27
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.4%
5 terminated out of 68 trials
84.4%
-2.2% vs benchmark
1%
1 trials in Phase 3/4
15%
4 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 27 completed trials
Clinical Trials (68)
MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study
Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD
SPSIPB vs SAPB for Thoracoscopic Surgery
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
LUCINAE Registry: Thoracic Cancers During Pregnancy
Prospective Data Collection Initiative on Thoracic Malignancies
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Evaluation of On-Couch CBCT Image Quality
Variability and Post-op AEs: Does Preoperative CardioPulmonary Variability Assessment Identify Risk of Postoperative Adverse Events Following Thoracic Surgery
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Thoracic Surgery by the Medtronic Hugo™ Robotic System
Curatively Intended Thoracic Reirradiation